iq4i research & consultancy published a new report on “ablation device global market –...

IQ4I Research & Consultancy Pvt. Ltd.

Ablation Device Global Market

–Forecast to 2023

Ablation Device Global Market estimated to be worth $20.9 billion by 2023 IQ4I Research & Consultancy published a new report on “Ablation Device Global

Market – Forecast To 2023” This report analyzes and studies the overall market, major

drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and

Rest of the World

IQ4I’s Report Contains 112 market data tables and 61 figures spread through 365

pages and an exhaustive TOC on “Ablation Device Global Market [TECHNIQUES

((Thermal (Cryoablation, Radiation, Radiofrequency, Laser, Microwave, Ultrasound &

Hydrothermal), Non-Thermal (Electroporation, Mechanical & Others)), APPLICATIONS

(Cancer, Cardiovascular (Atrial Fibrillation, Ventricular Tachycardia, Others)

Ophthalmology, Cosmetology, Gynecology, General Surgery, Urology, Orthopedics,

Pain Management & Others ), END-USERS (Hospitals, Ambulatory Surgical Centers &

Specialty Clinics), REGIONAL (North America (U.S., Others), Europe (U.K., Germany,

France, Others), Asia Pacific (India, China, Japan, Others) and Rest of the World

(Brazil, Middle East, Others))]

This report analyzes the ablation device global market in terms of market revenue ($ million)

for all segments and it enables ablation device stakeholders such as Ablation device

products manufacturers, distributors and wholesalers, OEM Manufacturers, Clinical

laboratories and hospitals, Various research and consulting firms, Contract manufacturing

organizations (CMOs), Group Purchasing Organizations (GPO’s), Surgical device players to

identify and analyze market expansion opportunities, upcoming technologies and

competition in ablation device global market.

Ablation is a process of tissue removal by either minimally invasive procedures or through

surgical procedures using thermal or non thermal technologies. The procedures date to as

old as 1981, when the first catheter ablation was performed on humans for treating atrial

fibrillation. Since then ablation technology have grown over time and have emerged as more

sophisticated, easy to use next-generation devices for treating conditions such as cancer,

pain, epilepsy, eye disorders, cosmetic skin corrections, abnormal uterine bleeding,

hypertension, benign prostatic hyperplasia, Barret’s oesophagus and asthma. Ablation

technology sorts are generally differentiated based on the type of energy utilized. These

include laser, radiation, radiofrequency, ultrasound, freeing cold temperature, chemical,

hydrothermal, microwave, and mechanical.

The ablation device global market is expected to grow at the high single digit CAGR due to

the increase in the incidence of cardiac diseases. According to IQ4I Analysis, the ablation

device global market is valued at $11,766.6 million in 2016 and is expected to reach



–Forecast to 2023

$20,995.5 million by 2023. Increasing number of ablation procedures, rising incidence of

cancer, an emergence of next-generation ablation products and technologies, growing

adoption of minimally invasive procedures, and improving reimbursement scenario in

established markets are some of the factors driving the market. However, reuse and

reprocessing of devices in developing countries, healthcare cost-containment measures,

stringent regulatory guidelines, and challenges in therapeutic procedures are some of the

factors hampering the market.

Ablation devices are categorized based on the technology or the modality that is used to

bring about ablation as thermal and non-thermal mode of ablation. Thermal technologies are

further segmented into radiofrequency, freezing cold temperatures (Cryoablation), laser,

microwave, radiation, ultrasound and hydrothermal energy. These ablation devices bring

about heating of the tissue by using any one of the energy source and ablate the tissue.

Non-thermal technologies include irreversible electroporation, mechanical and other modes

of ablation (Chemical). Radiofrequency ablation has been the established standard, but

cryoablation and microwave ablation technologies are soon set to out par the radiofrequency

market and indicate high growth potential.

Many hybrid technologies are entering the market, and are expected to have a great position

in future due to its dual mechanism capabilities. The Sonata (Sonography-Guided

Transcervical Fibroid Ablation) System by Gynesonics is an advanced technology platform

integrating miniaturized sonographic guidance with radiofrequency ablation in a single

delivery system for transcervical treatment of a wide range of uterine fibroid types and sizes.

By application, the market is segmented into oncology, cardiovascular (atrial fibrillation,

ventricular tachycardia, and others), ophthalmology, cosmetology, gynecology, urology,

orthopedics, pain management and others. While the various ablation techniques make

them flexible devices for use in an extensive variety of surgical methods, the highest

utilization is witnessed in cancer therapy for the removal of cancerous tissue, followed by

cardiovascular and then the general surgery applications. Similarly by end-users, the market

is segmented into hospitals, ambulatory surgical centers, and specialty clinics and increased

reimbursement facility is aiding for the growth of hospitals.

North America accounted for the largest share in the ablation device market and is estimated

at in 2016. The existence of well established healthcare infrastructures utilizing sophisticated

and advanced ablation technologies is responsible for high growth in this region. On the

other hand, Asia Pacific region is expected to grow high with a double digit CAGR by 2023.



–Forecast to 2023

The growth is attributed to increasing healthcare awareness among people for early

diagnosis and rising government expenditure on healthcare services.

The key players in the ablation device global market include Boston Scientific Corporation

(U.S.), Johnson and Johnson (U.S.), Abbott laboratories (St Jude Medical) (U.S.), Medtronic

(Ireland), Stryker Corporation (U.S.), Elekta AB (Sweden), Olympus Corporation (Japan),

ConMed Corporation (U.S.), Hologic (U.S.), Articure Inc. (U.S.), Angiodynamics Inc. (U.S.),

Smith and Nephew plc (U.K.), and Varian Medical Systems (U.S.).

Other key players in the market are Halyard Health (U.S.), BTG PLC (U.S.), Insightec

(Israel), EDAP Tms (France), SonaCare Medical (U.S) and Misonix (U.S.)

Reasons for buying this report:

Identification and analysis of the ablation device market segments by techniques,

applications, end-users and geography

Analysis of the global market by identifying various sub-segments of the ablation

device market

Revenue forecast of the ablation device global market and strategic analysis of each

submarket with respect to individual growth trends

Revenue forecast of the ablation device market with respect to North America (U.S.,

Others), Europe (U.K., Germany, France, Others), Asia-Pacific (India, China, Japan,

Others) and the Rest of the World (RoW) (Brazil, Middle East, Others) regions

Identification of the major market trends and factors driving or inhibiting the growth of

the ablation device global and its various sub-markets

Analysis of the opportunities for stakeholders by identifying the high-growth

segments of the market

Profiles of major players in the ablation device global market with details of their

product offerings, business strategies and SWOTs

Market shares for overall ablation device market, atrial fibrillation & radiation therapy,

market share for application by thermal technology, oncology types share, patent

analysis, upcoming technology, reimbursement, regulatory scenario, and supply

chain analysis, procedure volume, average selling price and procedural cost for each

technology

Established and Emerging players (109 companies) and their product offerings.



–Forecast to 2023

FIGURE 1

ABLATION DEVICE GLOBAL MARKET SEGMENTATION

Ablation Devices Global

Market

By Technology

Thermal

technology

By Application By End Users

Non-Thermal

technology

Cryoablation

Radiation

Radiofrequency

Laser

Mechanical

Electroporation

Other

Ultrasound

Microwave

Hydrothermal

Hospitals

Ambulatory

Surgical Centers

Specialty Clinics

Cancer General Surgery

Ophthalmology

Cosmetology

Gynecology

Cardiovascular

Urology

Pain Management

Orthopedics

Atrial Fibrillation

Ventricular

Tachycardia

Others

Others

iq4i research & consultancy published a new report on “ablation device global market –...

Healthcare